학술논문
Safety and efficacy of nabiximols on spasticity symptoms in patients with motor neuron disease (CANALS): a multicentre, double-blind, randomised, placebo-controlled, phase 2 trial
Document Type
Article
Author
Formaglio, Fabio; Rossi, Paolo; Clerici, Marta; Falzone, Yuri Matteo; Pozzi, Laura; Martinelli, Daniele; Cerri, Federica; Lopez, Ignazio Diego; Martinelli-Boneschi, Filippo; Quattrini, Angelo; Pieri, Elisabetta; Marinou, Kalliopi; Querin, Giorgia; Sansone, Valeria; Maestri, Eleonora; Calvo, Andrea; Chio, Adriano; Riva, Nilo; Mora, Gabriele; Sorarù, Gianni; Lunetta, Christian; Ferraro, Ottavia E; Falzone, Yuri; Leocani, Letizia; Fazio, Raffaella; Comola, Mauro; Comi, Giancarlo
Source
In The Lancet Neurology February 2019 18(2):155-164
Subject
Language
ISSN
1474-4422